541 related articles for article (PubMed ID: 31094101)
21. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia and Skeletal Muscle Quality as Predictors of Postoperative Complication and Early Mortality in Gynecologic Cancer.
Silva de Paula N; de Aguiar Bruno K; Azevedo Aredes M; Villaça Chaves G
Int J Gynecol Cancer; 2018 Feb; 28(2):412-420. PubMed ID: 29266018
[TBL] [Abstract][Full Text] [Related]
23. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
[TBL] [Abstract][Full Text] [Related]
24. Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events.
Phuong A; Marquardt JP; O'Malley R; Holt SK; Laidlaw G; Eagle Z; Ngo S; Orcutt D; Schade GR; Lin DW; Schweizer MT; Yezefski T; Yu EY; Montgomery B; Grivas P; Fintelmann FJ; Psutka SP
Urol Oncol; 2022 Oct; 40(10):456.e19-456.e30. PubMed ID: 36028450
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
26. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Liu J; Yu X; Huang X; Lai Q; Chen J
Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
[TBL] [Abstract][Full Text] [Related]
27. Muscle radiodensity and mortality in patients with colorectal cancer.
Kroenke CH; Prado CM; Meyerhardt JA; Weltzien EK; Xiao J; Cespedes Feliciano EM; Caan BJ
Cancer; 2018 Jul; 124(14):3008-3015. PubMed ID: 29797673
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with variability in skeletal muscle radiodensity in patients with metastatic cancer.
Calixto-Lima L; Wiegert EVM; de Oliveira LC; Chaves GV; Avesani CM; Bezerra FF
Nutrition; 2024 Apr; 120():112351. PubMed ID: 38330891
[TBL] [Abstract][Full Text] [Related]
29. Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer.
Weng CS; Huang WC; Chang CL; Jan YT; Chen TC; Lee J
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2114-2125. PubMed ID: 37503876
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
Williams GR; Deal AM; Muss HB; Weinberg MS; Sanoff HK; Nyrop KA; Pergolotti M; Shachar SS
Oncotarget; 2017 May; 8(20):33658-33665. PubMed ID: 28431396
[TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle is prognostic in resected stage III malignant melanoma.
Youn S; Eurich DT; McCall M; Walker J; Smylie M; Sawyer MB
Clin Nutr; 2022 May; 41(5):1066-1072. PubMed ID: 35397311
[TBL] [Abstract][Full Text] [Related]
32. Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival.
Huang X; Ma J; Li L; Zhu XD
Cancer Med; 2019 Nov; 8(15):6604-6613. PubMed ID: 31517443
[TBL] [Abstract][Full Text] [Related]
33. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
Kurk S; Peeters P; Stellato R; Dorresteijn B; de Jong P; Jourdan M; Creemers GJ; Erdkamp F; de Jongh F; Kint P; Simkens L; Tanis B; Tjin-A-Ton M; Van Der Velden A; Punt C; Koopman M; May A
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):803-813. PubMed ID: 31094083
[TBL] [Abstract][Full Text] [Related]
35. Racial differences in body composition and survival among older adults with gastrointestinal malignancies.
Aleixo GFP; Hess DL; Fowler ME; Giri S; Williams GR
J Geriatr Oncol; 2024 May; 15(4):101747. PubMed ID: 38513310
[TBL] [Abstract][Full Text] [Related]
36. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
37. Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy.
Cortellini A; Palumbo P; Porzio G; Verna L; Giordano AV; Masciocchi C; Parisi A; Cannita K; Ficorella C; Bozzetti F
Thorac Cancer; 2018 Dec; 9(12):1623-1630. PubMed ID: 30259689
[TBL] [Abstract][Full Text] [Related]
38. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M
PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652
[TBL] [Abstract][Full Text] [Related]
39. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
40. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
